Table 1  Demographic and laboratory findings of the study cohort.
Control   Af-sensitized   ABPA  Fungal colonization   Total
n  16  3  3  7  29
Age (years) (median ± 5–95 percentile)  43 (26-61)  35 (27-44)  21 (17-24)  42 (22-62)  38 (18-62)
Male/female  7/9  1/2  0/3  5/2  13/16
Lung transplantation  12/16  3/3  0/3  4/7  19/29
Time since transplantation (median ± 5–95 percentile)  6 (1-19)  7 (4-14)  /  2 (1-10)  6 (1-17)
Bacterial colonization  9/16  1/3  3/3  6/7  19/29
Fungal colonization  7/16  2/3  3/3  6/7  18/29
Chest HRCT abnormality(ies)  14/16  2/3  3/3  7/7  26/29
Total IgE (kIU/L) (median ± 5–95 percentile)  73 (4–333)  72 (41–100)  414 (74–854)  12 (2–26)  94 (2–469)
IgE Af (kUA/L) (median ± 5–95 percentile)  <0.1  1 (0.1–2)  10 (3–19)  <0.1  1 (0–6)
Eosinophils (mm3) (median ± 5–95 percentile)  321 (107–623)  327 (161–602)  370 (135–775)  319 (149–565)  326 (128–692)
ABPA, Allergic bronchopulmonary aspergillosis; Af, Aspergillus fumigatus; HRCT, High-resolution computed tomography.